Downstream technology landscape for large-scale therapeutic cell processing

BioProcess International

Volumn 11, Issue SUPPL. 3, 2013, Pages 38-47

  Pattasseril, Jacob ^a   Varadaraju, Hemanthram ^a   Lock, LyeTheng ^a   Rowley, Jon A ^a  

^a Cell Therapy R and D Lonza Walkersville   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CULTURE; CELL THERAPY; CENTRIFUGATION; CRYOPRESERVATION; DOWNSTREAM PROCESSING; FUNDING; GAS PERMEABILITY; MEDICAL RESEARCH; MICROBIAL CONTAMINATION;

EID: 84876498565     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (15)

1. Mason C, et al. Cell Therapy Industry: Billion Dollar Global Business with Unlimited Potential. Regen. Med. 6(3) 2011: 256-272.
2. Culme-Seynour EJ, et al. A Decade of Cell Therapy Clinical Trials (2000-2010). Regen. Med. 7(4) 2012: 455-462.
3. Rowley JA, et al. Meeting Lot-Size Challenges of Manufacturing Adherent Cells for Therapy. BioProcess Int. 10(3) 2012: S16-S22.
4. Jones SD, McKee S, Levine HL. Emerging Challenges in Cell Therapy Manufacturing. BioProcess Int. 10(3) 2012: S4-S7.
5. Rowley JA. Developing Cell Therapy Biomanufacturing Processes. Chem. Eng. Prog. November 2010: S50-S55.
6. Botterill M. Single-Use Saves Time for Contract Manufacturing Organization. PharmaceuticalOnline 1 June 2011; www.pharmaceuticalonline.com/ doc.mvc/Single-Use-Saves-Time-For-Contract-0001.
7. Langer E. Budget for Single-Use systems on the Rise: CMOs the Biggest Spenders. Bioresearch Online 27 August 2012; www.bioresearchonline.com/doc.mvc/ budgets-single-systems-rise-cmos-biggest-spenders-0001.
8. CBER. Draft Guidance for Industry: Potency Tests for Cellular and Gene Therapy Products. US Food and Drug Administration: Rockville, MD, January 2011: www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ Guidances/CellularandGeneTherapy/ucm072571.htm.
9. Kalmin ND, Brown DJ. Platelet Washing with a Blood Cell Processor. Transfusion 22(2) 1982: 125-127.
10. Perotti CG, et al. A New Automated Cell Washer Device for Thawed Cord Blood Units. Transfusion 44(6) 2004: 900-906.
11. Zeman LJ, Zydney AL. Microfiltration and Ultrafiltration: Principles and Applications. Marcel Dekker: New York, NY, 1996.
12. van Reis R, et al. High Performance Tangential Flow Filtration. Biotech. Bioeng. 56, 1997: 71-82.
13. TB032: Protein Concentration and Diafiltration by Tangential Flow Filtration.EMD Millipore Corporation: Billerica, MA, 2003; www.millipore.com/ techservice
14. Scientific and Laboratory Services: Introduction to Tangential Flow Filtration for Laboratory and Process Development Applications. Pall Corporation: Port Washington, NY; www. pall.com/main/laboratory/literature- library-details.page?id=34212.
15. CDER/CVM/ORA. Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. US Food and Drug Administration: Rockville, MD, September 2004; www.fda.gov/downloads/Drugs/ .../Guidances/ucm070305.pdf.